PI3K/Akt/mTOR Signaling
Research Areas
Products Related to PI3K/Akt/mTOR Signaling(719)
- GC16304MK-2206 dihydrochlorideCAS: 1032350-13-2Purity: >98.00%
MK-2206 dihydrochloride is a pan-AKT allosteric inhibitor that inhibits AKT1 (IC 50 =8nM), AKT2 (IC 50 =12nM), and AKT3 (IC 50 =65nM).
- GC16366AKT Kinase InhibitorCAS: 842148-40-7Purity: >98.00%
AKT Kinase Inhibitor is a potent inhibitor of Akt kinase with antitumor activity.
- GC16379PI-103 HydrochlorideCAS: 371935-79-4Purity: >98.00%
PI-103 Hydrochloride is a potent cell-permeable multi-target inhibitor that primarily acts on the PI3K and mTOR signaling pathways.
- GC16702CHIR-99021 (CT99021)CAS: 252917-06-9Purity: >99.00%
CHIR-99021 (CT99021) is a kind of highly selective inhibitor of GSK-3, the IC 50 values for GSK-3α and GSK-3β are 10nM and 6.7nM respectively.
- GC169604,5,6,7-TetrabromobenzimidazoleCAS: 577779-57-8Purity: >98%
4,5,6,7-Tetrabromobenzimidazole is a selective and ATP competitive CK2 (casein kinase 2) inhibitor.
- GC17330(+)-UsniacinCAS: 7562-61-0Purity: >95.00%
(+)-Usniacin is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usniacin inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity. (+)-Usniacin possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium.
- GC17443Metformin HClCAS: 1115-70-4Purity: >98.00%
Metformin HCl (1,1-Dimethylbiguanide hydrochloride) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16304 | MK-2206 dihydrochloride | 1032350-13-2 | >98.00% | |
MK-2206 dihydrochloride is a pan-AKT allosteric inhibitor that inhibits AKT1 (IC 50 =8nM), AKT2 (IC 50 =12nM), and AKT3 (IC 50 =65nM). | ||||
| GC16366 | AKT Kinase Inhibitor | 842148-40-7 | >98.00% | |
AKT Kinase Inhibitor is a potent inhibitor of Akt kinase with antitumor activity. | ||||
| GC16379 | PI-103 Hydrochloride | 371935-79-4 | >98.00% | |
PI-103 Hydrochloride is a potent cell-permeable multi-target inhibitor that primarily acts on the PI3K and mTOR signaling pathways. | ||||
| GC16380 | AZD8055 | 1009298-09-2 | >99.50% | |
AZD8055 is a new ATP-competitive mTOR inhibitor with an IC 50 of 0.8 nmol/L and a K i of 1.3 nmol/L. | ||||
| GC16475 | Afuresertib | 1047644-62-1 | >99.50% | |
pan-AKT inhibitor | ||||
| GC16481 | XL388 | 1251156-08-7 | >99.00% | |
An mTOR inhibitor | ||||
| GC16534 | Ampkinone | 1233082-79-5 | >99.00% | |
AMPK activator | ||||
| GC16549 | WZ4003 | 1214265-58-3 | >97.00% | |
NUAK1/2 inhibitor, potent and selective | ||||
| GC16584 | TCS 21311 | 1260181-14-3 | >95.00% | |
A JAK3 inhibitor | ||||
| GC16601 | LJI308 | 1627709-94-7 | >99.00% | |
pan-RSK inhibitor | ||||
| GC16617 | IM-12 | 1129669-05-1 | >98.00% | |
GSK-3β inhibitor, potent | ||||
| GC16654 | CC-115 | 1228013-15-7 | >98.00% | |
mTOR/DNA-PK inhibitor | ||||
| GC16702 | CHIR-99021 (CT99021) | 252917-06-9 | >99.00% | |
CHIR-99021 (CT99021) is a kind of highly selective inhibitor of GSK-3, the IC 50 values for GSK-3α and GSK-3β are 10nM and 6.7nM respectively. | ||||
| GC16851 | AZD6482 | 1173900-33-8 | >99.50% | |
PI3Kβ inhibitor,potent and selective | ||||
| GC16904 | PIK-75 | 372196-77-5 | >99.50% | |
PIK-75 is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM). PIK-75 induces apoptosis. | ||||
| GC16960 | 4,5,6,7-Tetrabromobenzimidazole | 577779-57-8 | >98% | |
4,5,6,7-Tetrabromobenzimidazole is a selective and ATP competitive CK2 (casein kinase 2) inhibitor. | ||||
| GC17187 | LY2090314 | 603288-22-8 | >99.00% | |
A potent and selective inhibitor of GSK3 | ||||
| GC17199 | PIK-90 | 677338-12-4 | >99.00% | |
PI3K inhibitor,potent selective | ||||
| GC17204 | PT 1 | 331002-70-1 | >98% | |
AMPK activator, selective | ||||
| GC17330 | (+)-Usniacin | 7562-61-0 | >95.00% | |
(+)-Usniacin is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usniacin inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity. (+)-Usniacin possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium. | ||||
| GC17338 | GNE-317 | 1394076-92-6 | >99.00% | |
potent, brain-penetrant PI3K inhibitor | ||||
| GC17443 | Metformin HCl | 1115-70-4 | >98.00% | |
Metformin HCl (1,1-Dimethylbiguanide hydrochloride) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. | ||||
| GC17457 | FRATide | 251087-38-4 | >98% | |
GSK-3 inhibitor | ||||
| GC17500 | SU6656 | 330161-87-0 | >98% | |
SU6656 is a small-molecule indolinone that selectively inhibits Src, Yes, and Fyn at IC 50 values of 0.28μM, 0.02μM, and 0.17μM, respectively. | ||||
